2014
DOI: 10.1002/lary.24890
|View full text |Cite
|
Sign up to set email alerts
|

Etiopathogenesis of acquired cholesteatoma: Prominent theories and recent advances in biomolecular research

Abstract: This article summarizes the existing theories and provides conceptual insights into the etiopathogenesis of acquired cholesteatoma, with the aim of stimulating continued efforts to develop a nonsurgical means of treating the disorder.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
136
0
8

Year Published

2015
2015
2017
2017

Publication Types

Select...
9
1

Relationship

5
5

Authors

Journals

citations
Cited by 134 publications
(145 citation statements)
references
References 76 publications
1
136
0
8
Order By: Relevance
“…The annual incidence of cholesteatoma is greatly variable being dependent on plenty of factors including environmental, socioeconomic, ethnic, genetic, anatomical, and physiological ones [6]. Broadly speaking, it ranges from 9 to 12.6 per 100,000 in adults and 3 to 15 per 100,000 in children with male predominance [1,4,6]. Caucasian people show the highest prevalence (12.6 per 100,000) followed by Africans whilst the lowest prevalence is seen among Eskimos, possibly due to larger nasopharynx and wider auditory tube [1,4].…”
Section: Introductionmentioning
confidence: 99%
“…The annual incidence of cholesteatoma is greatly variable being dependent on plenty of factors including environmental, socioeconomic, ethnic, genetic, anatomical, and physiological ones [6]. Broadly speaking, it ranges from 9 to 12.6 per 100,000 in adults and 3 to 15 per 100,000 in children with male predominance [1,4,6]. Caucasian people show the highest prevalence (12.6 per 100,000) followed by Africans whilst the lowest prevalence is seen among Eskimos, possibly due to larger nasopharynx and wider auditory tube [1,4].…”
Section: Introductionmentioning
confidence: 99%
“…Grommet insertion has been reported to be an iatrogenic cause of secondary acquired cholesteatoma [81][82][83][84][85][86]. The development of the disease is quite uncommon, with a reported rate of approximately 1% in non-CLP children with VTI [73,87].…”
Section: Cholesteatomamentioning
confidence: 99%
“…Thus, some clinicians view VTI as the most viable treatment modality. Nevertheless, VTI can have several adverse effects, such as secondary acquired cholesteatoma or infectious otorrhea (incidence rate of 29% to 64%), which is the most common complication following tube placement and is often refractory to local or medical treatment [5,[8][9][10][11]. In summary, no effective strategies for the management of otologic symptoms based on conventional approaches have been developed.…”
Section: Conventional Management Options and Limited Therapeutic Effectsmentioning
confidence: 99%